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https://doi.org/10.1016/j.neuron.2019.04.029SUMMARY
Oxytocin (OT) release by axonal terminals onto the
central nucleus of the amygdala exerts anxiolysis. To
investigate which subpopulation of OT neurons con-
tributes to this effect, we developed a novel method:
virus-delivered genetic activity-induced tagging of
cell ensembles (vGATE). With the vGATE method,
we identified and permanently tagged a small sub-
population ofOT cells, which, by optogenetic stimula-
tion, strongly attenuated contextual fear-induced
freezing, and pharmacogenetic silencing of tagged
OT neurons impaired context-specific fear extinction,
demonstrating that the tagged OT neurons are
sufficient and necessary, respectively, to control
contextual fear. Intriguingly, OT cell terminals of
fear-experienced rats displayed enhanced glutamate
release in the amygdala. Furthermore, rats exposed to
another round of fear conditioning displayed 5-foldmore activated magnocellular OT neurons in a novel
environment than a familiar one, possibly for a gener-
alized fear response. Thus, our results provide first
evidence that hypothalamic OT neurons represent a
fear memory engram.
INTRODUCTION
Emotional memory representations (also called memory en-
grams), such as for fear, are pivotal for animal survival. Fear-
associated behaviors have evolved over millions of years in living
systems, from lower to higher animals, so that they can sense,
evaluate, respond, and adapt to adequately deal with dangerous
situations (Mobbs et al., 2015). Fear-related disorders, such as
specific phobias and post-traumatic stress disorder (PTSD),
are among the most prevalent human psychiatric conditions
and pose debilitating health burdens to affected individuals
and immense costs to society (Kessler and Bromet, 2013).
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for example, by targeted circuit-specific therapeutics.
The hypothalamus is an evolutionary old and deeply located
brain structure that relays fear-related emotional behavior in
mammals. Fear memory engrams are thought to be distributed
between the different brain regions in the nervous system; for
example, the amygdala, hippocampus, and medial prefrontal
cortex (mPFC) (Kitamura et al., 2017). Notably, the hypothalamus
is reciprocally connected to different brain regions, including the
amygdala (Knobloch et al., 2012) and themPFC (Heidbreder and
Groenewegen, 2003), which, in turn, interact with various other
brain regions when organizing fear memories (Tovote et al.,
2015). These findings support the view that brain networks,
composed of distributed cell assemblies, generate behavior,
including the formation of memory representations or engrams.
We thus hypothesized that the hypothalamus, being the oldest
brain structure, which evolved over time alongside the newer
higher brain structures, might be equipped with mechanisms
to encode engram-like features and capable of plasticity.
The central nucleus (CeA), a subregion of the amygdala, par-
ticipates in the acquisition, consolidation, storage, expression,
and extinction of fear memories (Ciocchi et al., 2010; Herry
et al., 2010; Letzkus et al., 2011) and the subsequent physiolog-
ical response: freezing behavior (Viviani et al., 2011). Hypotha-
lamic oxytocin (OT) neurons precisely project to the lateral part
of the CeA (CeL), where axonal OT release activates CeL neu-
rons (Knobloch et al., 2012), which, in turn, inhibit GABAergic
neurons in the medial part of the CeA (CeM), attenuating the
fear-related freezing response in rodents. However, the precise
role of OT neurons and their projections to the CeA during fear
learning is still not well understood. It is unknown which fraction
of OT neurons contributes to the anxiolytic effect, how OT neu-
rons are recruited during different fear episodes, and whether
the hypothalamus-amygdala circuit is subject to fear-dependent
plasticity and contextual specificity.
To tackle these questions, we developed a novel genetic
method, virus-delivered genetic activity-induced tagging of cell
ensembles (vGATE), to tag fear-experience-activated OT neu-
rons in rats during contextual fear conditioning (FC) (Ehrlich
et al., 2009; LeDoux, 2007). Here we provide first evidence that
establishes the role of OT neuronal ensembles in fear expression
and extinction. We discovered that optogenetic activation of a
small subset of fear exposure-activated OT neurons drastically
reversed freezing behavior (‘‘unfreezing’’) and their silencing
impaired context-specific fear extinction. Importantly, fear expo-
sure-taggedOT neurons display an enormous capacity for expe-
rience-dependent plasticity by enhancing glutamatergic overFigure 1. Operating Principle of the vGATE System and Activity-Depen
(A) Scheme of the vGATE system: virus 1 (rAAV-(tetO)7-Pfos-rtTA), virus 2 (rAAV-
(B) Rats were injected with vGATE viral cocktail (3 viruses) into the hypothalamic S
(C) Dox-dependent rtTA expression is only detected in the stimulus + Dox group.
mixed 1:1 with an rAAV expressing Venus under control of the oxytocin promote
(D) In euhydrated rats (basal, top panel), Dox injection induces rtTA-dependent Y
signals in a few scattered neurons. In contrast, both signals were detected in the m
salt-loaded rats (stimulated, bottom panel).
(E) Expression of the endogenous c-fos signal (visualized via immunohistochemist
SON OT neurons of Dox-treated, osmotically challenged rats.OT-ergic transmission in the hypothalamic-amygdalar circuitry.
These results clearly demonstrate that fear exposure-tagged
OT neurons are both sufficient and necessary for attenuation
of fear expression. Altogether, these results satisfy the key
criteria of the synaptic plasticity memory hypothesis (Martin
et al., 2000) in identifying and validating a fear memory engram
in hypothalamic OT circuits. Thus, we conclude that memory en-
grams are not only restricted to higher brain regions, such as the
hippocampus and cortex, but also present in a lower brain re-
gion, such as the hypothalamus. This study is a shift in paradigm,
revealing the anatomical and functional connectivity organiza-
tion of fear memory engrams as network-wide distributed cell
assemblies that include both higher and lower brain regions.
RESULTS
Activity-Dependent Tagging of OT Neurons
To specifically label activated OT neurons, we developed and
describe here a genetic method called vGATE (Figure 1A). In
the vGATE system, a c-fos promoter (Pfos) fragment (Schilling
et al., 1991) drives the expression of the reverse tetracycline-
sensitive (tet) transactivator (rtTA) (Dogbevia et al., 2015,
2016). In activated neurons, stimulation of the c-fos promoter
rapidly induces rtTA expression. To obtain sustained rtTA
expression for permanent tagging of c-fos activated neurons,
we designed an autoregulatory expression loop by introducing
rtTA-binding DNA sequences (tet operator sequences [(tetO)7])
upstream of Pfos to drive rtTA expression (the full genetic module
is (tetO)7-Pfos-rtTA). In the presence of doxycycline (Dox), tran-
sient Pfos activity drives rtTA expression, which, upon binding
to (tetO)7, takes over the transient c-fos promoter activity by
establishing a Dox-controlled rtTA-dependent and self-sustain-
ing autoregulatory loop (Figure 1A) for persistent rtTA expres-
sion. A second virus (virus 2) is equipped with a bidirectional
tet promoter (Ptetbi) that drives the expression of genes encoding
for the Cre recombinase and fluorescent proteins (Figure 1A).
Finally, a third virus (virus 3) is equipped with a cell-type-specific
promoter (OT in our case) that drives Cre-dependent expression
of any gene(s) (Figure 1A).
vGATE-Assisted, Dox-Dependent rtTA Expression
In Vivo
As a proof of principle, we first validated the vGATE method
in vitro (Figures S1A–S1D) and, subsequently, in vivo. For in vivo
validation, we injected the vGATE construct rAAV-(tetO)7-Pfos-
rtTA into the supraoptic nucleus (SON) of the hypothalamus.
Three weeks later, rats were treated under four differentdent Tagging of OT Neurons
Ptetbi-Cre/YC3.60), and virus 3 (rAAV-POT-FLEX-hChR2-mCherry).
ON and treated with Dox in combination with osmotic stimulation (salt loading).
To verify correct viral targeting of the SON, the rAAV-(tetO)7-Pfos-rtTA virus was
r (rAAV-POT-Venus; Knobloch et al., 2012).
C3.60 (via virus 2, green) and Cre-dependent ChR2-mCherry (via virus 3, red)
ajority of SON OT neurons (blue) after Dox injection to osmotically challenged,
ry, green) overlays vGATE-assisted the ChR2-mCherry signal (red) in virtually all
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induced robust c-fos expression in OT neurons (Katoh et al.,
2010; Figures 1B and 1C; Table S1). Only under the +Dox/+SL
condition, robust rtTA expression under a synthetic c-fos
promoter was detected (red) within 24 h in roughly all of the OT
neurons (Hamamura et al., 1991; Figure 1C). This result shows
that the vGATE method is compatible with endogenous c-fos
expression. With rAAV-POT-Venus as a tracer, it was possible
to verify proper virus targeting and spread of infection after
injection.
In a different set of experiments, we injected a cocktail of three
viruses called OTvGATE: (virus 1, rAAV-(tetO)7-Pfos-rtTA; virus 2,
rAAV-Ptetbi-Cre/YC3.60; virus 3, rAAV-POT-FLEX-humanized
channel rhodopsin (hChR2)-mCherry) and analyzed for YC3.60
(virus 2) and hChR2-mCherry (virus 3). Under +SL/+Dox robust
YC3.60 (Ptetbi-Cre/YC3.60) and hChR2-mCherry (Cre-depen-
dent,POT-FLEX-hChR2-mCherry) immunosignals were co-local-
ized in the majority of OT neurons (96.30% ± 1.88% SON,
97.22% ± 2.66% paraventricular nucleus (PVN); Figure 1D). In
these animals, we found that 2.4% ± 1.1% (48 of 2,011) of the
YC3.60/hChR2-mCherry-expressing cells in the PVN and
5.7%± 1.4% (132 of 2,320) of cells in the SONwere non-OTergic
(n = 6 animals). Under the +Dox /SL (Figure 1D) condition, we
found that 7.3% ± 2.2% YC3.60/hChR2-mCherry-positive cells
around the SON were non-OTergic (179 of 2,450 neurons) and
that 0.8% ± 0.5%YC3.60/hChR2-mCherry-positive cells around
the PVNwere non-OTergic (22 of 2,450 neurons, n = 6; n = animal
number, 6 sections per animal). These unidentified YC3.60/
hChR2-mCherry-positive cells were within a radius of 400 mm
from the border of the respective nucleus. Under SL/Dox
conditions (Figure S1E), we observed virtually no YC3.60 and
mCherry labeling (0.1% ± 0.03%, 5 of 540 for the PVN; 0.3% ±
0.09%, 22 of 722 for the SON; n = 6, 6 sections per animal), a
result of minimal leakiness of the Ptetbi. Furthermore, we
observed more than 93% (94.74% ± 1.75% for the SON and
93.56%± 2.46% for the PVN; Table S1) co-localization of endog-
enous c-fos and mCherry in vGATE animals subjected to SL for
5 consecutive days (Figure 1E).
Optogenetic Stimulation of Tagged OT Neurons
Reverses Freezing Behavior in Fear-Conditioned Rats
We investigated what fraction of the entire OT population actu-
ally contributes to the anxiolytic effect and how OT neurons
are recruited during the expression of fear using contextual FC
in rats (Figure 2A). We found that only a small number of OT neu-
rons in the SON and PVN expressed c-fos during fear exposure
(Figures S2A and S2B). Next we generated OTvGATE rats with
bilateral injections of the vGATE viral cocktail to permanently
tag activated OT neurons in the SON and PVN for activity manip-
ulation by hChR2 (virus 1, rAAV-(tetO)7-Pfos-rtTA; virus 2, rAAV-
Ptetbi-Cre/YC3.60; virus 3, rAAV-POT-FLEX-hChR2-mCherry)
(OTvGATE). We specifically chose day 3 for the Dox injection
because we wanted to exclusively label fear-activated OT neu-
rons but not pain-sensitive OT neurons. As a control, we gener-
ated rats that constitutively expressed rAAV-delivered hChR2 in
all OT neurons (OTConstitutive) in the SON and PVN. Although the
OTConstitutive group displayed viral expression in virtually all OT
neurons (99.4%± 0.8%, n = 4; Figure 2B1), in the OTvGATE group,4 Neuron 103, 1–14, July 3, 2019only a small fraction of the OT neurons was tagged during fear
expression (341 of 2,470, 13.8% ± 0.7% of OT neurons in
the SON and 331 of 2,666, 12.4% ± 1.6% of OT neurons in the
PVN) of 6,600 cells comprising the PVN and SON in rats
(Althammer and Grinevich, 2017; Figure 2B2; Table S2). We
found that only 1.2%of non-OTergic cells were labeled non-spe-
cifically (57 cells of 2,051 cells in total labeled via vGATE,
PVN/SON combined, n = 4, 6 sections per animal) in the fear-
conditioned animals (Figure S2C). To determine whether
OTvGATE neurons project axons terminating within the CeA sub-
region of the amygdala, we analyzed brain slices containing the
CeL and found mCherry-positive fibers in the CeL that were also
OT-immuno-positive (Figure 2B2). Optogenetic stimulation of
these OT axons in the CeL with blue light (BL) induced a promi-
nent decrease in the freezing response (unfreezing) in both
groups. Surprisingly, the BL-evoked unfreezing effect in the
OTvGATE group was much stronger (freezing time, 6.9 ± 1.1 s
versus 38.1 ± 7.6 s, p < 0.0001; Figure 2C2) and occurred faster
(onset, 3.8 ± 0.7 s versus 25.9 ± 10.8 s, p < 0.0001; Figure 2D)
than in the OTConstitutive group (Figures 2C1 and 2D). To rule
out that the observed behavioral changes were mediated by
brain regions other than the CeA, we injected 4 animals with
rAAV-(tetO)7-Pfos-rtTA, rAAV-Ptetbi-Cre/YC3.60, and rAAV-POT-
FLEX-GFP. Four animals injected with rAAV-POT-Venus served
as a control. We analyzed the brains of the vGATE-injected ani-
mals and did not find any GFP-positive fibers outside of the CeA,
whereas control animals showed prominent labeling of OT fibers
in various brain regions, as reported previously (Figure S2D;
Knobloch et al., 2012). This indicates that fear-activated,
vGATE-labeled OT neurons project exclusively to the CeA. In
addition, we did not find a single mCherry-positive fiber in the
CeA that was negative for OT immunoreactivity (n = 6 animals,
6 sections per animal, in which more than 15 mm of total
axon length was analyzed), indicating that axonal projections
from vGATE-labeled axons exclusively represent OT fibers.
Conversely, we found no difference between OTConstitutive
(98.2% ± 1.4%, n = 6) and OTvGATE (96.9% ± 2.1%, n = 6) groups
regarding the labeling of OT-positive fibers in the CeL, indicating
that all OT neurons projecting to the CeL are fear-sensitive. Next,
to provide additional proof that OTvGATE neurons precisely proj-
ect to the CeA, we injected green Retrobeads into the CeA of rats
with OTvGATE neurons labeled by mCherry. The anatomical
analysis revealed that 94.6% ± 3.1% of mCherry-positive OT
neurons (1,337 OTvGATE neurons, PVN/SON combined, n = 4)
contained green Retrobeads (Figure S2E), indicating that the
vast majority of OTvGATE neurons project to the CeA.
Because our FC paradigm comprised an additional shock ses-
sion (day 14, memory reinforcement) to achieve higher basal
freezing rates, we wanted to rule out the possibility that this
session leads to recruitment of new OT cells. Therefore, we per-
formed another experiment in which animals were injected with
rAAV-(tetO)7-Pfos-rtTA and rAAV-Ptetbi-Cre/YC3.60 and sub-
jected to our FC paradigm (day 3 Dox injection, day 4 shock;
Figure S2F). On day 14, animals received an injection of rAAV-
POT-FLEX-hChr2-mCherry and were subjected to another round
of FC 2 weeks later. Then one group received another Dox injec-
tion, and the control group was injected with saline one day prior
to the additional shock session on day 29 (Figure S2F). Although
Figure 2. Fear Learning and Optogenetic Control of Fear Behavior
(A) Scheme of the fear condition setup, Dox administration, and blue light stimulation of the CeA.
(B) The vastmajority of OT neurons (99.4%± 0.8%, green) of the PVN and SONwere labeled via a constitutive OT promoter driving hChR2-mCherry (B1, red). (B2)
Fear expression induced tagging (ChR2-mCherry, red) of a small population of OT neurons (green). (B1 and B2) Vertical panels depict ChR2-mCherry-containing
axons (red) with OT-immunopositive puncta (green, appearing in yellow) in the CeL of both groups.
(C) The freezing time before and after blue light illumination of the CeA (C1, top graph: constitutive hChR2 expression, OTConstitutive group; C2, bottom graph:
OTvGATE group). The black bars (control) show the freezing time immediately prior to BL stimulation, whereas the blue bars (BL) indicate the freezing time after BL
stimulation. ***p < 0.001, t test.
(D) The onset and duration of the BL-induced unfreezing effect. Data are presented as mean ± SEM.
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labeling (224 of 2,033, 11% ± 1.4% for the PVN; 260 of 1,940,
13.4% ± 1.7% for the SON; n = 5; Figure S2G) of OT neurons,
we only found a total of 11 mCherry-positive cells in the PVN
(11 of 2,020, 0.5%, n = 5) and 17 mCherry-positive cells in the
SON (17 of 2,177, 0.8%, n = 5) in the group receiving saline in
the first round (Figure S2G). Thus, this experiment demonstrates
that, after Dox has been cleared from the brain, only few addi-
tional OT cells get labeled. To verify that the comparable labeling
of cells also held true on the axonal level, we compared OT-pos-
itive fibers within the CeA of animals perfused after 14 days with
animals perfused after 43 days (2 weeks after the day 29 shock
session; Figure S2F) and found no difference in vGATE-mediated
labeling (day 14: 96.9% ± 2.1%, n = 6; day 43: 95.3% ± 3.1%,
n = 6).
Because a recent study highlighted the existence of freezing-
promoting (somatostatin-ergic) and flight-promoting (cortico-
tropin-releasing hormone-ergic) neurons (Fadok et al., 2017),
we sought to find out which cell types within the CeL are
activated upon BL stimulation. Therefore, we injected rats with
our vGATE viruses (rAAV-(tetO)7-Pfos-rtTA and rAAV-Ptetbi-Cre/
YC3.60) and either rAAV-POT-FLEX-Venus (n = 4) or rAAV-POT-
FLEX-hChr2-mCherry (n = 4) and subjected them to our FC
protocol (Figure 2A). On day 15, we illuminated the CeL for
2 min and sacrificed animals 90 min later. We found that fear
exposure itself did not cause c-fos expression in the CeL,
whereas BL stimulation robustly induced c-fos in this structure.
In the BL-stimulated animals, we counted 888 corticotropin-
releasing hormone (CRH)-positive neurons and 290 SOM-
positive neurons, whereas 104 neurons expressed both
markers. 84% ± 3.6% of exclusively SOM-positive neurons,
11% ± 0.9% of exclusively CRH-positive neurons, and 58% ±
4.3% of the mixed population expressed c-fos (Figure S2H).
Thus, these findings suggest that OT release in the CeL predom-
inantly activates SOM-positive interneurons.
Fear-Experience-Dependent Anatomical and Functional
Plasticity of Hypothalamic OT Neurons Projecting to
the CeA
To investigate potential anatomical and molecular changes
following fear experience, we generated OTvGATE rats (virus 3,
rAAV-POT-FLEX-GFP) and quantitatively analyzed OT axons
within the CeL. In parallel, we analyzed fear-naive rats express-
ing POT-Venus for constitutive labeling of all OT neurons
(OTConstitutive; Figure 3A1). Although the total length of axonal
segments was similar in both groups (Figure 3A3), there was a
substantial increase (3-fold) in the numbers of GFP-positive
axonal varicosities containing immunosignals of vesicular gluta-
mate transporter 2 (vGluT2) in the OTvGATE group (Figure 3A3;
Table S3). Furthermore, we found that the detectable OT levels
in vGATE fibers were at least 3-fold lower compared with the
fear-naive animals injected with POT-Venus, potentially resulting
from the enhanced glutamate expression (fear-naı¨ve, 58.0% ±
8.4%; fear-experienced, 15.3% ± 3.1%; signal intensity, n = 4;
6 sections per animal; Figure S3A).
To elucidate the seemingly counter-intuitive observation that
activation of a small subset of OT neurons resulted in a stronger
behavioral response than activation of axons originating from6 Neuron 103, 1–14, July 3, 2019virtually all OT neurons (OTConstitutive group) in the CeL, we next
aimed to investigate the underlying circuitry within the CeA by
ex vivo electrophysiology in acute brain slices from fear-naive
OTConstitutive and fear-experienced OTvGATE groups (Figure 2D).
In the naive group, all OT neurons constitutively expressed
hChR2 (OTConstitutive), whereas in the OTvGATE group, a small
fraction of OT neurons was labeled with the vGATE virus cocktail
(virus 3, POT-FLEX-hChr2-mCherry). In both groups, BL stimula-
tion of OT axons in the CeL (Figure 3B) induced an increase in
inhibitory postsynaptic current (IPSC) frequencies in neurons of
the CeM, which receive direct synaptic input from GABAergic
neurons of the CeL (Figure 3C1). Interestingly, the BL-induced in-
crease in CeM IPSC frequencies in the OTvGATE group was
almost entirely blocked by the glutamate AMPA receptor antag-
onist NBQX, whereas it only had a minor effect on the control
group (Figure 3C2). On the other hand, the application of
the OT receptor antagonist dOVT diminished the BL-induced
increase in CeM IPSCs in the OTvGATE group by only 50%,
whereas it prevented the increase in CeM IPSCs in the control
OTConstitutive group entirely (Figure 3C2).
To rule out that the observed differences were not a result of
the fear experience, we injected an additional group of animals
with rAAV-POT-hChR2-mCherry (OT
Constitutive) and subjected
them to the same paradigm as theOTvGATE group (Figure 2A; Fig-
ure S3B1). Analysis of the fear-conditioned OTConstitutive group
revealed that the BL-induced unfreezing effect, onset, and dura-
tion ofmobility time (Figures S3B2–S3B4) aswell as the effects of
NBQX and dOVT on IPSC frequencies in CeM neurons (Figures
S3B5–S3B7) were comparable with those observed in the
OTvGATE group (Figures 2C, 2D, 3C1, and 3C2). These findings
suggest that the initial exposure to FC induced plastic changes
in OT neurons, resulting in prevalent release of glutamate from
their axonal terminals within the CeL. Because of the similarity
of behavioral and amygdala responses to OT axon stimulation
in fear-experienced OTConstitutive and OTvGATE groups, the
observed effects might stem from the same population of OT
neurons naturally activated in both groups of rats during fear
expression (Figure 2B).
To test whether the ex vivo findings have a functional rele-
vance in vivo, we blocked the OT receptor specifically with an
antagonist (OTA, L-368,899, 1 mg/kg intraperitoneally [i.p.])
that crosses the blood-brain barrier (Eliava et al., 2016). First,
we injected rats bilaterally in the SON and PVN with
POT-hChR2-mCherry (OT
Constitutive) for optogenetic tagging and
implanted optic fibers into the CeA (Figure 3D1). Next we sub-
jected the animals to the FC paradigm. On day 3, treatment of
the animals with OTA 40 min prior to BL stimulation (session 1,
OTA + BL1) completely prevented the BL-induced unfreezing ef-
fect (Figure 3D2). However, 2 weeks later, when we exposed the
very same animals to the second session of FC (session 2, OTA +
BL2), the animals displayed a rapid BL-induced unfreezing
response despite prior application of OTA (Figure 3D3). Interest-
ingly, the onset of BL-induced unfreezing occurred much faster
(6 ± 0.8 s versus 25.9 ± 10.8 s, p < 0.0001; Figure 3D4) than in
the fear-naive OTConstitutive group (Figure 2D). To exclude that
the observed unfreezing effects were a result of OTA-induced
changes in plasticity originating from the first round of FC,
we processed an additional group of animals constitutively
Figure 3. Functional Plasticity of the OT System upon Fear Learning
(A) GFP-labeled axons of OT neurons in the CeL of naive OTConstitutive (A1) and OTvGATE (A2) rats. Shown are an overview and enlarged fragments, showing
co-localization of GFP (green) with OT (blue) and vGluT2 (red). (A3) Quantification of total axonal lengths and vGluT2-immunoreactive puncta. Green, OT axons
containing no vGluT2; yellow, co-localization of OT and vGluT2; st, stria terminalis. *p < 0.05, ***p < 0.001, t test.
(B) Scheme of the ex vivo recording setup.
(C) Effect of optical stimulation of OT-ergic axons present in the CeL (BL) on IPSC frequencies recorded in CeM neurons in both fear-naive and fear-
experienced vGATE animals (C1). Pie charts depict the proportion of CeM neurons responding to BL (naive OTConstitutive, n = 27 of 56; OTvGATE, n = 23 of 78,
not significant).The bar plot shows the change in CeM current frequencies (hertz) in response to BL. Data are expressed as means across slices plus SEM.
Individual values are indicated as white circles. **p < 0.01, ***p < 0.001, two-way ANOVA followed by Sidak post hoc test. (C2) Pharmacological dissection of
BL effects. Left: quantification of the effect of NBQX (green; naive OTConstitutive, n = 7; OTvGATE, n = 5) or dOVT (red; OTConstitutive, n = 7; OTvGATE, n = 6)
application on the initial BL effect on IPSC frequencies recorded in the same CeM neurons. Data are expressed as means across slices plus SEM. Individual
values are indicated as white circles. ***p < 0.001, Mann-Whitney test. Right: Z scores illustrating the time course and modulation of BL effects by NBQX
or dOVT.
(D) Scheme of BL stimulation of the CeL in OTConsitutive animals pretreatedwith OTA (D1). (D2 and D3) The bar charts display the freezing time in the corresponding
group and after blue light stimulation of the CeA after OTA administration. Top graph: the first conditioning session (D2, OTA-BL1). Bottom graph: the second
conditioning session (D3, OTA-BL2). The black bars (control) show the freezing time immediately prior to BL stimulation, whereas the blue bars (BL) indicate the
freezing time after BL stimulation. ***p < 0.001, t test. (D4) Graph displaying the onset and duration of the BL-induced unfreezing effect.
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Figure 4. Pharmacogenetic Inhibition of OT
Neurons Impairs Fear Extinction
(A) Scheme of the FC setup in contexts A and B
(context A, green wall; context B, red wall). Virally
injected animals were subjected to contextual
FC. After two shock sessions (day 1 and day 2),
animals received an i.p. injection of Dox on day 3,
followed by another session on day 4 without
shocks. Ten days later, animals were subjected to
an additional shock day to reinforce the fear
memory and then underwent a 4-day fear extinc-
tion protocol. During the extinction session, ani-
mals received a daily injection of CNO 40 min prior
to the experiment. After exposure to context B,
animals were subjected to 2 days of shock,
followed by another 4-day extinction session,
where they again received CNO daily prior to the
experiment.
(B) Bar charts showing the average freezing time of
animals over the course of a 4-day fear extinction
paradigm as well as the total increase in mobility;
e1–e4 indicate extinction days. (B1) Although
control animals underwent normal fear extinction,
CNO-mediated silencing of all OT neurons equally
impaired fear extinction in both contexts. **p <
0.01, ***p < 0.0001, t test. (B2) CNO-mediated
silencing of vGATE-tagged OT neurons in context
A impaired fear extinction in context A but not in
context B. **p < 0.01, ***p < 0.0001, one-way
ANOVA.
(C) Schematic depiction of the local CNO infusion
onto the CeA (C1). (C2) Confocal image showing
the site-specific infusion of Retrobeads following
CNO infusion to verify proper targeting of the CeA.
(C3) Local infusion of CNO into the CeA impaired
fear extinction in context A but not context B. *p <
0.05, **p < 0.01.
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of OTA) in the first session and OTA in the second session, and
obtained similar results (Figures S3C1–S3C3) as in the initial
group, which was treated with OTA in both sessions (Figure 3D).
Thus, our data indicate that fear experience drives a shift from
OT to glutamate release from OT axons in the CeL of fear-
experienced groups. Moreover, the enhanced responsiveness
of CeL neurons to glutamate and its correlated effect, which
could be abolished by application of NBQX (Figure 3C2), may
indicate a transient, fear-experience-induced upregulation of
AMPA receptors in these cells.
Inhibition of Fear-Activated OT Neurons Impairs Fear
Extinction in a Context-Dependent Manner
To provide further evidence that OT neurons activated by fear
exposure attenuate fear expression, we hypothesized that
silencing of OTvGATE neurons inhibits fear extinction specifically
in the context where these neurons had originally been activated.
Therefore, rats (n = 6) were injected with a virus expressing the8 Neuron 103, 1–14, July 3, 2019modified human muscarinic receptor
hM4D(Gi) under control of the OT pro-
moter exposed to contextual FC and
extinction paradigms (Figure 4A). All fourgroups of animals (OTvGATE A-A, OTvGATE A-B, OTConstitutive
A-A, and OTConstitutive A-B) were subjected to FC in context A
(day 1 shock, day 2 shock, day 3 Dox injection, day 4 exposure).
To induce fear extinction, the two groups (OTvGATE A-A and
OTConstitutive A-A) were exposed to the same context A for four
consecutive days (40 min each session) without any electrical
shock, receiving a daily i.p. injection of clozapine-N-oxide
(CNO) 40 min prior to testing (control groups received saline).
In parallel, we processed two additional groups of animals
(OTvGATE A-B and OTConstitutive A-B, n = 6) in analogy to the first
groups that were submitted to a first round of FC (in context A)
and then transferred to a novel context (context B; Figure 4,
blue star) prior to being submitted to the extinction protocol.
We introduced the novel context (context B) to specifically inves-
tigate the potential role of OT in context-dependent fear extinc-
tion. This context represented a novel environment that was
distinct in terms of visual, tactile, and olfactory cues (Figure S4A).
Importantly, rats conditioned in context A did not display contex-
tual FC in context B (Figure S4B), clearly demonstrating that
Please cite this article in press as: Hasan et al., A Fear Memory Engram and Its Plasticity in the Hypothalamic Oxytocin System, Neuron (2019), https://
doi.org/10.1016/j.neuron.2019.04.029animals are able to discriminate between the two boxes (the
complete dataset on freezing behavior is provided in Table S4).
Silencing of all OT neurons by constitutively expressed hM4D(Gi)
and application of its agonist CNO resulted in impaired fear
extinction in both contexts A and B (Figure 4B1; Table S4). We
next applied the vGATE technique to express hM4D(Gi) specif-
ically in OT neurons (virus 3, rAAV-POT-hM4D-Gi). We discov-
ered that the silencing of OT fear neurons that were tagged in
context A impaired fear extinction in context A but not in the
novel context B (Figure 4B2). Because CNO has been reported
to potentially activate certain neurons (Gomez et al., 2017), we
performed control experiments (without virus injection, n = 6),
where CNO alone had no effect on context-specific fear extinc-
tion (Figure S4C). To further rule out that the observed differ-
ences in fear extinction dynamics were a result of the two
different contexts, we subjected naive, non-injected animals to
fear extinction sessions in both contexts and found comparable
freezing times throughout the extinction sessions (n = 6;
Figure S4D).
To demonstrate that the observed impairments in fear extinc-
tion stem from inhibition of local OT release onto the CeA, we
injected rats (n = 8) with the vGATE cocktail (virus 3, rAAV-POT-
hM4D-Gi) and implanted bilateral guide cannulas above the
CeA for local infusion of CNO (Figures 4C1–4C2). CeA local infu-
sion of 1 mM CNO (Stachniak et al., 2014) 15 min prior to each
session impaired fear extinction in context A but not context B
(Figure 4C3), confirming our previous results. To verify proper
targeting of the CeA, we infused Retrobeads immediately after
the last extinction session and killed the animals 10 min later to
avoid spreading of the tracer (Figure 4C2). The control group
(n = 8) injected with vGATE-GFP viruses displayed normal fear
extinction in both contexts, indicating that local infusion of
CNO per se does not impair fear extinction (Figure 4C3).
Activity of OT Neurons in the SON Is Context Dependent
To shed light on the cellular mechanisms underlying the context-
dependent effect of neuronal inhibition (Figure 4B2), we labeled
the OTvGATE neurons green with the rAAV-POT-FLEX-GFP
(virus 3) and co-stained sections for endogenous c-fos red to
identify the fraction of OT cells that was active during re-expo-
sure to the same context (Figure 5A). In line with previous results
(Figure 2B2), the first round of context A FC induced tagging of
10.8% of OT neurons in the PVN and 11.9% in the SON, visual-
ized by intrinsic GFP (Figure 5A). The second round of context A
FC induced c-fos signal in 9.5% of OT neurons in the PVN and
16.2% in the SON (Figure 5A). The overlap of virally expressed
GFP and c-fos was 18% in the PVN and 89% in the SON, sug-
gesting context-dependent activity of OT neurons specifically
in the SON as well as a functional difference between the two
nuclei. The difference in re-activation of OT cells in context
A/A versus context A/B was significant for the SON (context
A-A, 89% ± 5.5%; context A-B, 22% ± 3.6%; n = 6, p < 0.0001)
but not the PVN (context A-A, 18% ± 2.7%; context A-B, 31% ±
3.7%; n = 6, p = 0.2805; Table S5). It is important to note that the
group of animals that was first exposed to context A displayed
5 times more activated neurons in both the PVN and SON after
further exposure to context B (PVN: context A vGATE-GFP,
9.6%; context B c-fos, 47.1%; SON: context A vGATE-GFP,11.7%; context B c-fos, 56.4%; Figure 5B; Table S5). This
5-fold difference in neuronal OT activity in context B correlated
with the dramatically increased OT concentration in the blood
(27.64% ± 5.4% pmol/mL versus 86.7% ± 12.9% pmol/mL; Fig-
ure S5A). However, despite themassive recruitment of new cells,
the overlap of GFP-positive and c-fos-expressing OT neurons in
the SON in context B amounted to only 22%. Taken together,
these results indicate that re-exposure to a familiar FC context
reactivates the same fraction of OT neurons, whereas exposure
to a novel context recruits an entirely different population of cells.
Therefore, it is plausible that OT neurons participate in a long-
lasting fear memory engram that coordinates the OT-ergic
response to different contextual fear episodes.
Finally, to investigate whether OT engram cells display basic
electrophysiological properties distinct from non-engram OT
cells, we performed an additional experiment where we injected
animals (n = 12) with vGATE (virus 3, POT-FLEX-GFP) and POT-
mCherryChr2 into the SON only. Animals were fear-conditioned,
received an injection of Dox on day 3, and were processed for
ex vivo patch-clamp recordings. In these animals, non-engram
OT cells expressed red fluorescence, whereas vGATE-labeled
engram cells appeared in yellow (green + red) (Figure 5C1). We
analyzed access resistance, membrane capacitance, mem-
brane potential, spontaneous excitatory postsynaptic current
(EPSC) amplitudes and frequencies, and discharge profile
upon current steps. Interestingly, we found significant differ-
ences in membrane capacitance (OT non-engram: 20.81 ±
1.25 pF, n = 16; OT engram: 26.13 ± 1.52 pF, n = 24; p < 0.05;
Figure 5C2) and frequency of spontaneous EPSCs (OT non-
engram, 1.87 ± 0.51; OT engram, 3.18 ± 0.54 Hz; p < 0.05;
Figure 5C2). All other parameters did not significantly differ be-
tween OTConstitutive and OTvGATE cells (Figure S5B). Thus, these
findings suggest that vGATE-labeled OT engram cells have a
larger membrane surface and receive more excitatory inputs, a
feature of engram cells that has already been described for the
hippocampus (Kitamura et al., 2017; Ryan et al., 2015).
To investigate whether increased glutamatergic input onto
OTvGATE could potentially underlie the observed differences in
membrane capacitance and increased spontaneous EPSCs,
we stained brain slices of vGATE-injected rats with the vesicular
glutamate transporter vGluT2 and compared the number of
vGluT2-positive puncta in the immediate surroundings (surface
of soma and 5-mm radius around each OT-positive neuron).
We found that the number of vGluT2 puncta encompassing the
OT engram (OTvGATE) cells (18.6 ± 1.2, 130 cells, n = 3) was signif-
icantly higher (p < 0.001) compared with non-engram OT neu-
rons (8.3 ± 0.9, 1,044 cells, n = 3) (Figure 5C3). These results
suggest that OT engram cells receive more prominent glutama-
tergic input than OT non-engram cells, potentially explaining the
unique electrophysiological properties of engram OT neurons
(Figure 5C2).
Parvocellular OT Neurons Activate Magnocellular OT
Neurons in a Novel Context
Because the OT system is composed of two types of neurons,
magnocellular (magnOT) and parvocellular (parvOT) neurons
(Rhodes et al., 1981; Swanson and Kuypers, 1980; Swanson
and Sawchenko, 1983), we next aimed to investigate whichNeuron 103, 1–14, July 3, 2019 9
Figure 5. Context-Dependent Tagging of OT
Neurons
(A and B) Percentage of OT neurons tagged in
context A and reactivated after exposure to a
familiar (A) or a novel (B) context. Shown are
representative confocal images of the PVN and
SON with an intrinsic GFP signal (green, vGATE-
based tagged neurons in context A) co-stained for
OT (blue) and c-fos (red, indicates neurons acti-
vated in context B). Pie charts show the relative
numbers and percentages of GFP-positive and
c-fos-expressing OT neurons in each hypothalamic
nucleus. In the PVN, the initial exposure to context
A resulted in GFP-based tagging of 10.8% of all
counted OT neurons (Table S5), whereas re-
exposure to the same context led to c-fos
expression in 9.5% of OT neurons with 18% of
reactivated cells (i.e., OT cells expressing GFP and
c-fos). In the SON, exposure to context A activated
11.9%of OT neurons, and re-exposure to the same
context induced c-fos in 16.2% of OT cells, dis-
playing an 89% overlap in GFP and c-fos signals.
For context B, the initial exposure activated 9.6%
of OT cells in the PVN, visualized by intrinsic GFP
expression, and the second exposure recruited a
massive 47.1% of OT cells with a reactivated GFP-
expressing fraction of 31%. In the SON, first
exposure to novel context B activated 11.7% of OT
neurons, whereas re-exposure to the same context
resulted in drastically increased activation of
56.4% of cells but reflecting only a 22% overlap of
GFP and c-fos.
(C) Electrophysiological properties of OTvGATE
versus OTConstitutive neurons. (C1) Experimental
scheme showing OTvGATE in yellow (co-localization
of green and red signals) and OTConstitutive in red in
the SON. (C2) Bar plots and individual data (dots) of
spontaneous excitatory postsynaptic current
(sEPSC) frequency (left) and membrane capaci-
tance (right) recorded in OTvGATE (yellow, n = 24)
and OTConstitutive (red, n = 16). *p < 0.05, t test. (C3)
VGluT2-immunoreactive puncta (green) in close
vicinity of OT neurons (blue) labeled by vGATE
viruses (FLEX-mCherry, red) and non-labeled OT
cells of the SON. The number of vGLuT2-positive
puncta in the vicinity of OT vGATE neurons is
significantly higher compared with non-labeled OT
neurons (p < 0.001).
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doi.org/10.1016/j.neuron.2019.04.029hypothalamic OT cell types are reactivated during the two fear
episodes. To distinguish betweenmagnOT and parvOT neurons,
we used the retrograde marker Fluorogold (FG), which labels
magnOT but not parvOT cells (Naumann et al., 2000). Injecting
the cocktail of vGATE viruses (virus 3, rAAV-POT-FLEX-GFP),
we found that virtually all FG-negative parvOT neurons of the
PVN (parvOT neurons are not present in the SON) were labeled
with GFP in context A and contained c-fos in context B, whereas10 Neuron 103, 1–14, July 3, 2019only a small fraction (14%–20%) of FG-
positive magnOT neurons of the PVN
and SON labeled with GFP in context A
were c-fospositive in context B (Figure 6A;
Table S6).Following previous findings that PVN parvOT neurons provide
synaptic inputs onto OT neurons in the SON to activate magnOT
neurons (Eliava et al., 2016), we aimed to silence parvOT neurons
to elucidate their functional relevance in the novel context B
during repeated fear exposure. To achieve this, we expressed
hM4D(Gi) in a Cre-dependent manner in the PVN via a CAV2-
Cre virus injected into the SON (Figure 6B) to silence parvOT in-
puts onto magnOT neurons. We found that silencing of parvOT
Figure 6. Pharmacogenetic Silencing of
Parvocellular OT Neurons
(A) Percentage of parvOT and magnOT, tagged in
context A byGFP and reactivated after exposure to
context B, and representative confocal images of
FG-positive (magnOT neurons, red) and FG-nega-
tive (parvOT neurons) containing intrinsic GFP and
c-fos (white). Green arrows indicate OT neurons
activated in context A (GFP), red arrows indicate
magnocellular OT neurons, and white arrows indi-
cate OT cells containing c-fos. Pie charts between
confocal images display the distribution of c-fos
labeling in parvOT and magnOT neurons.
(B) Experimental setup for exclusive silencing of
ParvOT neurons. Animals received an injection of
CAV2-Cre into the SON and Cre-dependent rAAV
expressing hM4Di-mCherry under the control of
the OT promoter into the PVN to specifically label
parvocellular OT neurons in the PVN. The confocal
image shows parvocellular OT cells (blue) ex-
pressing hM4Di-mCherry (red).
(C–F) Images of the SON of naive animals (C), rats
conditioned in context A (D), and rats conditioned
in context A followed by context B and treatedwith
vehicle (E) or CNO (F).
(G) CNO treatment drastically reduced the number
of c-fos-expressing OT neurons in the SON of rats
exposed to context B. Black, control; green,
exposure to context A; red, exposure to context
B plus saline injection; blue, exposure to context
B plus CNO injection. ***p < 0.0001, one-
way ANOVA.
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doi.org/10.1016/j.neuron.2019.04.029neurons in context B prevented the massive induction of c-fos
expression in the SON (Figures 6C–6G; Table S6), indicating a
critical role of parvOT neurons during repeated fear exposure.
Similar results were obtained in the PVN (Figures S6A–S6E), sug-
gesting that parvOT neuronsmight also directly or indirectly con-
trol magnOT activity within PVN neurons. To exclude that the
prevented rise in c-fos expression was a result of CNO treat-
ment, we subjected animals to the same paradigm, where they
received CNO but were not injected with Cre-dependent
hM4D(Gi) rAAV, and found no differences in c-fos expression
in OT neurons of the SON and PVN (Figure S6F).
DISCUSSION
Here we provide first evidence that vGATE-assisted OT-tagged
neurons during fear expression are sufficient for controlling
fear behavior and necessary for fear extinction. Furthermore,
fear experience drives enormous plasticity, mediating a shift
from OT to glutamate signaling in the CeL. We propose that
repeated fear exposure activates OT-ergic fear engram cells
for rapid adaptive behavioral responses.
The Context-Dependent Fear Memory Engram and Its
Plasticity in the Hypothalamic OT System
The hypothesis that learning-activated cell ensembles form
memory engrams has received substantial attention (Kitamura
et al., 2017; Liu et al., 2012; Reijmers et al., 2007). Although
memory engrams have been discovered in higher brain re-
gions such as the cortex, hippocampus, or basolateral amyg-dala (Kitamura et al., 2017; Liu et al., 2012), no study, to
our knowledge, has addressed the potential role of the
lower brain regions, such as the hypothalamus, in the
modulation of fear memory. In a number of studies, the OT
system has been highlighted as a key structure modulating
various aspects of fear, such as acquisition, expression, and
extinction.
To investigate whether OT neurons encode for context-
specificity, we applied the vGATE method to identify and manip-
ulate potential OT engram cells and labeled a small fraction
(11%–14%) of hypothalamic OT neurons by contextual FC.
Remarkably, the majority of OTvGATE neurons project to the
CeA, and optogenetic activation of the OT neuronal axonal fibers
in the CeA elicited rapid onset of unfreezing. We further found
that, upon fear exposure, OT neurons show enhanced glutama-
tergic over OT-ergic transmission in the CeM (Figure 3D1) with
increased membrane capacitance (Figure 5C2) and elevated
vGluT2-levels in OT axons terminating in the CeA (Figure 5C3),
consistent with previous studies (Ciocchi et al., 2010; Li et al.,
2013; Penzo et al., 2015). Thus, our results provide the first
evidence for fear-induced long-term plasticity (15 days) of the
OT-CeL circuit. It seems indeed possible that a single episode
of fear conditioning permanently alters the OT and glutamate
balance, perhaps to strengthen synaptic connections for rapid
response and memory maintenance. These findings support
the general notion that coordinated release of slow-acting neuro-
modulator peptides and fast-acting amino acid transmitters
could be a likely mechanism to modulate cognitive, emotional,
and metabolic processes (van den Pol, 2012).Neuron 103, 1–14, July 3, 2019 11
Figure 7. Context-Dependent Changes in
OT Neuron Activity Following Contextual
Fear Experience
The scheme represents a working hypothesis of
plasticity and contextual specificity of the central
OT system. At the level of OT terminals in the
amygdala (top panel), the fear learning process
induces drastic changes in the transmitter and
neuromodulator balance: although in naive rats,
OT axons predominantly release OT, in fear-
experienced rats, the same axons release
glutamate instead of OT. At the level of the hypo-
thalamus (center panel), the majority of magnOT
neurons in the SON exhibit context specificity and
are not reactivated in a novel context. In contrast,
parvOT neurons of the PVN, synapsing on SON
magnOT neurons, are reactivated in a novel
context and drive massive recruitment of new
magnOT neurons. The massive activation of new
SONOT neurons correlated with OT release to the
blood, serving homeostatic adaptation to exces-
sive stress caused by exposure to a novel fearful
environment (bottom).
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doi.org/10.1016/j.neuron.2019.04.029Based on our findings, we hypothesized that OTvGATE engram
neurons might also be involved in fear extinction. Given the key
role of CeA in fear extinction, we next investigated whether
context-specific OT neuronal circuits would control context-
specific fear extinction. Although inhibition of virtually all OT
neurons resulted in context-independent impairment of fear
extinction, inhibition of OTvGATE neurons exclusively affected
fear extinction in the context in which the cells had originally
been labeled. These OTvGATE neurons might be required for sup-
pression of memory expression, safety cues, and priming for
extinction. This could explain the unaffected fear extinction of
animals in context B after silencing of OTvGATE neurons that
were tagged in context A, where inhibition of these fibers might
no longer be relevant, because newly recruited OT neurons in
a different context could compensate for the reduced release
of OT in the CeA by release of this neuropeptide in other brain re-
gions (Figures 4B2 and 4C3). Therefore, we concluded that
silencing of OTvGATE engram cells impaired fear extinction,
demonstrating necessity, a likely result of blocking OT and gluta-
mate-mediated neural modulation in the CeA. We propose that
OTvGATE cells represent a ‘‘neuromodulatory’’ engram that12 Neuron 103, 1–14, July 3, 2019plays a vital role in controlling simple
‘‘contextual memory’’ representations
for context-specific behavioral expres-
sion and the extinction phenotype.
Context-Independent Control by
Parvocellular OT Neurons of the
Hypothalamic OT System
OT neurons are divided into two types:
magnOT and parvOT neurons. Despite
their relatively low numbers (70 neurons
per rat), parvOT neuronsmodulate impor-
tant physiological processes, such as
cardiovascular functions, hunger, andpain (Althammer and Grinevich, 2017). The present study high-
lights the functional relevance of parvOT neurons in contextual
FC because virtually all parvOT neurons that were activated in
context A were also reactivated in context B, and silencing of
parvOT neurons almost entirely blocked the recruitment of novel
magnOT neurons in an unfamiliar context. Therefore, we hypoth-
esize that parvOT neurons operate as a class of ‘‘master cells,’’
orchestrating magnOT neuron activity and subsequent OT
release into the blood. Although the precise role of OT neurons
during fear conditioning remains to be determined, it is plausible
that the coordinated activity of parvOT neurons may facilitate
global priming effects and/or induce plasticity of magnOT neu-
rons in various physiological demands (Theodosis et al., 1986;
Tobin et al., 2012). In line with this, global activation of the OT
system, driven by parvOT neurons, can be crucial for metabolic,
autonomic, and behavioral adaption to exacerbated fear-
induced stress. In our current study, the 5-fold increase in
c-fos expression quite accurately matches the 5-fold elevation
of OT levels in the blood (Figure S6A). This indicates that newly
activated OT neurons in context B are magnOT cells that release
the neuropeptide from the neurohypophysis into the blood.
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doi.org/10.1016/j.neuron.2019.04.029Thus, the newly recruited OT neurons in both hypothalamic
nuclei provide a massive release of OT into the peripheral circu-
lation to regulate various physiological demands to cope with an
exacerbated stress response (Yang et al., 2013).
Conclusion
We identified and validated a neuromodulatory engram
composed specifically of OT cells that fulfills the key criteria of
the synaptic plasticity memory hypothesis (Martin et al., 2000):
sufficiency, necessity, and plasticity. We demonstrated that OT
neurons of the SON participate in a fear memory engram (Fig-
ure 7), whereas parvOT neurons coordinate OT release in a
context-independent manner. Our findings will facilitate the
investigation of pathophysiological mechanisms underlying
emotion-associated mental disorders, especially PTSD symp-
toms, their potential treatment by exogenous OT (Althammer
et al., 2018; Frijling et al., 2014), and virus-delivered genetically
based targeted therapeutic agents.
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dkfz-heidelberg.de.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
Anatomical, electrophysiological, optogenetic and behavioral studies were performed with female Wistar rats purchased from
Janvier, France (8-10 weeks old on arrival at our facility). All rats were housed under standard conditions with ad libitum access
to food andwater. All experiments have been approved by theGerman Animal Ethics Committee of the BadenW€urttemberg (licenses
numbers 35-9185.81/G-24/12, 35-9185.81/G-26/15 and 35-9185.81G-102/17) and the French Ministry of Research (APAFIS#3668-
2016011815445431 v2).
METHOD DETAILS
The vGATE system
Generation and cloning
We engineered a synthetic c-fos promoter linked to its first exon (Exon 1; (Schilling et al., 1991) with ATGs in the Exon 1 converted to
TTGs by site directedmutagenesis and heptamerized tetracycline (tet) operators, (tetO)7, added upstreamof it. These operators drive
the expression of a humanized reverse tet transactivator (rtTA) (Dogbevia et al., 2015) named (tetO)7-Pfos-rtTA. The entire cassette
was subsequently cloned in a plasmid to produce recombinant adeno-associated viruses (rAAVs) packaged with serotype 1 and 2
(Dogbevia et al., 2015) to generate Virus1 (rAAV-(tetO)7-Pfos-rtTA). Next, an AAV equipped with bidirectional tet promoter (Ptetbi) ex-
pressing the Cre-recombinase was linked to a genetically-encoded calcium indicator (YC3.60) (Virus 2, rAAV-Ptetbi-Cre/YC3.60,
(L€utcke et al., 2010)). As the last component of our viral technique (Virus 3), we generated rAAVs under the OT promoter to drive
expression of hChR2-mCherry, GFP or hM4D(Gi)-mCherry (Eliava et al., 2016; Grund et al., 2017) in a Cre-dependent manner.
The entire system comprising rAAV-(tetO)7-Pfos-rtTA (Virus 1), as the key element of the system, combined with rAAV-Ptetbi-
Cre/YC3.60 (Virus 2) and the Cre-dependent ‘FLEX’ viruses (Virus 3, see Key Resources Table) for ‘virus-delivered, Genetic
Activity-dependent Tagging of cell Ensembles’ or vGATE. In the vGATE method, the c-fos promoter drives rtTA expression only
when neurons are activated. The rtTA generated by transient c-fos promoter activity binds to the upstream (tetO)7 only in the pres-
ence of Dox. This way, the rtTA drives its own expression, thus establishing an autoregulatory loop, even when the induced c-fos
promoter activity declines to baseline levels as neuronal activity subsides. Therefore, only in the presence of Dox, the rtTA can
activate the expression of the bidirectional tet promoter (Ptetbi) to express any gene of choice, for example, the Cre recombinase,
for permanent tagging of activated cells via a Cre-dependent FLEX cassette.
Validating in cultured neurons
Dissociated rat hippocampal cultured neurons were treated with two viruses (rAAV-(tetO)7-Pfos-rtTA + rAAV-Ptetbi-Cre/tdTOM) for
two weeks. Afterward, cells were treated with bicuculline (bic) for 20 min and replaced with fresh medium supplemented with Dox
(1 mg/ml) for 24 h. Only in the presence of bic andDox, a strong rtTA signal was detected by immunohistochemistry (Figure S1, bottom
panel). By live fluorescence imaging of fixed cells, rtTA-dependent tdTOM expression was also clearly detected in +bic/+Dox treated
cells. In a few neurons, however, tdTOM expression was also detected under condition of –bic/+Dox. This is likely a result of
spontaneous activity in some neurons. Western blot analyses validated tdTOM expression (Figure S1).
Novelty of the method
We describe here a genetic method (vGATE) that uses c-fos promoter elements to drive expression of a reverse tetracycline trans-
activator (rtTA). The key novelty of our method is that the ‘recording period’ can be rapidly opened within a few hours by a singlee2 Neuron 103, 1–14.e1–e8, July 3, 2019
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doi.org/10.1016/j.neuron.2019.04.029intraperitoneal Dox injection before the tagging of activated neurons. In previous methodological studies, we carefully characterized,
both ex vivo and in vivo, the regulation of Dox-controlled gene expression by rtTA expressed under a human synapsin promoter (Dog-
bevia et al., 2015; Dogbevia et al., 2016). We determined an optimal Dox concentration for in vivo application, and the time course of
gene activation and inactivation by a single intraperitoneal Dox injection. In our previous studies, we found that the bidirectional Tet
promoter (Ptetbi) has highly reduced leakiness (Dogbevia et al., 2016) compared to the uni-directional Tet promoter (Ptet) (Dogbevia
et al., 2015). Indeed, Ptet is very leaky (Dogbevia et al., 2015), due to its close proximity close to an inverted terminal repeat (ITR) of
AAV, which appears to have intrinsic enhancer-like activity (Dogbevia et al., 2015). This raises potential concerns that AAVs equipped
with a uni-directional tet promoter (Ptet) might be leaky enough to non-specifically tag non-engram cells. With these considerations,
we characterized the vGATEmethod both ex vivo and in vivo. The vGATEmethod is very tightly controlled and highly flexible; different
combination of gene modules in rAAVs can be simultaneously delivered to the targeted brain region(s). With this approach, we per-
formed selective and cell-type-specific tagging of OT neurons activated during contextual fear learning and expressed in the tagged
neurons gene(s)-of-interest for pharmacogenetic and optogenetic manipulations, while others might easily target different neuronal
populations.
Different methods exist to induce time-dependent conditional protein expression, namely the TetTag (Reijmers et al., 2007) and the
TRAP (Guenthner et al., 2013) methods. The TetTag method drives tTA expression under c-fos and animals have to be fed Dox to
keep the system inactive. However, to open the recording period, TeTag animals have to be switched to diet without Dox for a
few days before performing learning-dependent neuronal labeling. However, this non-recording period of a few days is sensitive
for non-specific labeling of neurons. In the case of vGATE, the presence of Dox is requested to activate detectable gene expression
within a few hours and achieved themaximumexpression after 24 h (Dogbevia et al., 2015, 2016) and gene expression is switched-off
in 6 days (Dogbevia et al., 2016). In a previous systematic study (Dogbevia et al., 2016), we found similar time course of 6 days to
‘‘re-activate’’ (with the tTA system) by Dox removal and ‘‘activate’’ (with the rtTA system) gene expression by Dox addition. The
discrepancy for 3 days for Dox clearance by others using the tTA system is likely due to the sensitivity of the detection method;
we used a highly sensitive reporter, the firefly luciferase, for gene expression assay as a proxy for Dox clearance from the brain (Dog-
bevia et al., 2016), while other labs use GFP (Liu et al., 2012), which are much less sensitive.
In the TRAP method, the inducer, tamoxifen, is needed to facilitate release cytoplasmic ER-Cre for transport to the nucleus to
permanently tag neurons by Cre/loxP dependent gene modules. However, TRAP is in itself leaking, since it is known that a fraction
of ER-Cre can already move to the nucleus even without tamoxifen treatment. There is even a bigger concern that tamoxifen as a
selective estrogenmodulator might interfere with various estrogen-sensitive cell types in the brain. The use of tamoxifen is especially
critical for OT neurons, which are sensitive for estrogens (Somponpun and Sladek, 2003) and tamoxifen itself triggers the activity of
the OT gene promoter (Koohi et al., 2005). Finally, tamoxifen induces c-fos expression in OT neurons (F.A. and V.G., unpublished
data), thereby precluding the use of the ER-Cre method for this particular neuron type. With our novel vGATE technique, we achieved
highly specific labeling of OT neurons and precise temporal control, whichwe believe to be superior to other comparable, c-fos based
tagging methods. Therefore, the development of the vGATE method should be able to overcomes the key inherent concerns of the
previous two main strategies to induce time-dependent conditional protein expression.
Infecting rat hypothalamic neurons in vivo with rAAVs
Cloning of the OT promoter, as well as the production and purification of rAAVs, has been previously described (Knobloch et al.,
2012). rAAV genomic titers were determined with QuickTiter AAV Quantitation Kit (Cell Biolabs, San Diego, California, USA) and
RT-PCR using the ABI 7700 cycler (Applied Biosystems, California, USA). rAAVs titers were between 1010 - 1011 genomic copies
per 1 ml. Infection of OT neurons was achieved by complementing the two viruses indicated above by an rAAV, driving genes of in-
terest (Venus, hChR2-mCherry, FLEX-GFP, FLEX-hM4D and hM4D(Gi). A cocktail of the three rAAVs (i.e., rAAV-(tetO)7-Pfos-rtTA,
rAAV-Ptetbi-Cre/YC3.60, and rAAV-POT-Venus) was injected bilaterally into the hypothalamic nuclei, the PVN and SON, using a
previously described protocol (Knobloch et al., 2012).
Neuroanatomy
To trace, label and manipulate the hypothalamus-amygdala connections, rAAVs expressing vGATE viruses were injected into the
PVN and SON. Alternatively, CAV2-Cre was injected into the SON, while the Cre-dependent ‘’FLEX’’ POT-hM4D(Gi) rAAV was in-
jected into the PVN to specifically label and manipulate parvOT neurons. After transcardial perfusion with 4% PFA, brains were
sectioned and stained with antibodies against OT, vGluT2, GFP, FG and dsRed. Images for qualitative and quantitative analyses
were taken on the confocal microscope Leica SP5.
BEHAVIOR
Salt loading
To validate the vGATE system in vivo, we performed salt-loading (SL) as a stimulus to activate c-fos expression in OT neurons (Katoh
et al., 2010). Here, we used a mixture of two rAAVs (rAAV-(tetO)7-Pfos-rtTA and rAAV-POT-Venus) and co-injected them unilaterally
into the SON of rats. The animals were divided into four groups (n = 3/group): Group 1 (Untreated control animals (-Dox/-SL)), Group 2
(-Dox/+SL, 7 days with SL (2%NaCl in drinking water), Group 3 (+Dox/-SL, normally hydrated animals, which received single Dox i.p.Neuron 103, 1–14.e1–e8, July 3, 2019 e3
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doi.org/10.1016/j.neuron.2019.04.029injection) and Group 4 (+Dox/+SL, animals received a single i.p. injection of Dox on the 5th day of SL and were kept under SL for 2
more days before being sacrificed). Expression patterns of the individual groups are depicted in Figure 1D.
Contextual fear conditioning and optogenetics
We used a mixture of three vGATE viruses as depicted (Figure 1A). Two weeks after the viral infection, adult female rats were sub-
jected to either a 3-day (single fear) or 15-day (double fear) contextual fear conditioning protocol, comprising a conditioning session
on the first 2 days and a recall session on the 3rd day (Figure 2A). All sessions lasted for 20min with 7 random foot shocks (1.6mA, 1 s)
dispersed between the 10th and 17th min of protocol during the fear conditioning session.
As shown in Figure 2A, animals were treated with Dox (5mg/kg b.w., i.p.) 24 h after the 2nd day of fear acquisition to tag OT neurons
activated during fear expression. The experimental group (animals injected with the vGATE system: rAAV-(tetO)7-Pfos-rtTA + rAAV-
Ptetbi-Cre/YC3.60 + rAAV-POT-FLEX-hChR2-mCherry) received another re-conditioning session (double fear), two weeks after Dox
injection and recovery, for one day, to achieve a higher level of freezing (above 50 s/min) and 24 h later were tested for the recall of fear
behavior with blue light (BL) illumination of the CeA. The CeA was illuminated bilaterally with BL (473 nm, 10 ms pulse, 20 s duration,
30 Hz) via 200 mm optical fibers from Thorlabs (BFL37 200) at the 10th min of the recall session. The rats were evaluated for freezing
responses and freezing durations were measured through freezing software (Panlab) and manually through an offline video in addi-
tion. In Figure 2C, the 2 different graphs display the average freezing time per minute in the corresponding groups (OTConstitutive and
OTvGATE) before and after BL illumination. The black bars (control) show the average freezing times inminutes immediately prior to the
BL illumination, whereas the gray bars (BL) indicate the average freezing times per minute during the minute in which the BL-induced
onset of the unfreezing effect (i.e., where the first signs of mobility appear). All groups of animals were sacrificed 90min after the start
of the optogenetic session.
Estimation of the estrous cycle
To monitor ovarian cycle, we performed vaginal smear collections. Animals in metestus, proestrus and estrus phases were excluded
from experiments and reintroduced once they reached diestrus.
Pharmacogenetics (DREADD) and fear extinction in Contexts A and B
In this experiment, animals were subjected to a series of fear conditioning and fear extinction paradigms that we performed in two
different contexts (A and B). For this purpose, two visually distinct contextual fear conditioning chambers were used, which were
comparable in size, shape of the grid and power of the electrical shocks (1.6 mA). The chambers were located in two different insti-
tutes (chamber A, Max Planck Institute of Medical Research (MPI), Heidelberg, Panlab; chamber B, Interdisciplinary Neurobehavioral
Core (INBC), Heidelberg, Med Associates) and the animals were exposed to them for the first time in both cases. Animals were in-
jected with POT-hM4D(Gi) (OT
Constitutive) or rAAV-(tetO)7-Pfos-rtTA, rAAV-Ptetbi-Cre/YC3.60 + rAAV-POT-FLEX-hM4D(Gi) (OT
vGATE)
and subjected to the experimental procedure after recovery and handling. For the contextual fear conditioning, animals were placed
in a fear conditioning chamber (Panlab, Harvard Apparatus) with a metal grid for application of electrical foot shocks (1.6 mA). We
used a 3-day fear conditioning protocol (2 days shock, 1 day testing, each 20 min) to fear condition the animals. On the first two
days, the animals, after a 10 min habituation period, received 7 electrical foot shocks within 7 min (randomly distributed, on average
1 shock per min), followed again by 3 min without shocks. For activation of the viral system, animals received Dox (5 mg/kg b.w., i.p.)
on day 3 of the fear conditioning (24 h after the 2nd shock day of the first round of fear conditioning). On the fourth day (24 h after
injection), animals were placed in the same box for 20 min without any shocks. The experiment was recorded with a video camera
and sensors in the grid measured the total movement of the animals during the procedure. After a 2-week break (Dox clearance and
viral expression) animals were exposed to the box in a second session. Here, we used a 5-day fear extinction protocol with one re-
conditioning day (in order tomaintain a high level of freezing (above 50 s/min) and identical in all groups) and 4 testing days. Due to the
2-week interval in between the two rounds, animals received electrical shocks on the first day (recall session), followed by 4 days on
which the animals were placed in the box for 40 min each without any shocks (extinction sessions). Animals expressing the
hMD4D(Gi) receptor in all OT neurons (OTConstitutive) or tagged OT neurons (OTvGATE) received a daily injection of Clozapine (3 mg/
kg bw i.p., Tocris Bioscience, Bristol, UK, dissolved in 1xPBS) 30 min prior to placing them into the Context A chamber. The control
groups (OTConstitutive and OTvGATE) received the same volume of 0.9% NaCl solution. After the first round of fear extinction in Context
A, animals were transferred to Context B. Here, an additional round of fear extinction was performed, which comprised two shock
sessions followed by 4 consecutive daily extinction sessions, 40min prior to which the animals received a daily injection of CNO (Fig-
ure 4A), whereas the control group received the same volume of 0.9%NaCl solution 40min prior to the start of the session. All animals
were sacrificed and perfused 90 mins after the fear conditioning session in Context B. In the two control groups, the time of freezing
in both contexts was almost identical (Figure S4B). Therefore, for the sake of simplicity, only the freezing time of OTConstitutive and
OTvGATE control groups in Context A is depicted in Figures 4B1 and 4B2.
Context A versus Context A - mapping of OT neuronal activity via GFP followed by immunostaining for c-fos
Animals were injected in all nuclei with the vGATE system (rAAV-(tetO)7-Pfos-rtTA + rAAV-Ptetbi-Cre/YC3.60 + rAAV-POT-FLEX-GFP)
and subjected to the 3-day contextual fear conditioning paradigm after recovery and handling. Following the first two shock sessions,
animals received Dox (5mg/kg b.w., i.p.) on the 3rd day of the fear conditioning paradigm. On the 4th day, animals were exposed to the
fear conditioning chamber, this time without electrical shocks. Two weeks after the 1st round of fear conditioning in Context A (1), the
animals were exposed to Context A(2) for a second time, where they underwent an additional session of fear conditioning. All animals
were sacrificed 90 min after the beginning of the test session in Context A (2).e4 Neuron 103, 1–14.e1–e8, July 3, 2019
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Animals were injected with the vGATE system into all nuclei (rAAV-(tetO)7-Pfos-rtTA + rAAV-Ptetbi-Cre/YC3.60 + rAAV-POT-FLEX-
GFP) and subjected to the 3-day contextual fear conditioning paradigm after recovery and handling. Following the first two shock
sessions, animals received Dox (5 mg/kg b.w., i.p.) on the 3rd day of the fear conditioning paradigm. On the 4th day, animals were
exposed to the fear conditioning chamber, this time without electrical shocks. After the 1st round of fear conditioning in Context
A, the animals were transferred to Context B, there they underwent an additional session of fear conditioning in analogy to that in
Context A, one week later. All animals were sacrificed 90 min after the beginning of the test session in Context B. This point in
time was chosen as it is well established that the c-fos protein has its peak expression at around 90 min after the initial activation
of OT neurons. To label all neuroendocrine cells protruding beyond the blood brain barrier (most importantly, magnOT neurons),
animals received a single injection of Fluorogold, Santa Cruz Biotechnology, Dallas, 15 mg/kg bw i.p. dissolved in 1xPBS, 7 days
prior to perfusion (Eliava et al., 2016).
DREADD-based inhibition of parvocellular OT neurons of the PVN in Context B
For this experiment, rats were injected with the retrogradely spreading rAAV-CAV2-Cre into the SON and rAAV-POT-FLEX-hM4D into
the PVN to specifically express hM4D in parvOT neurons of the PVN, in analogy to our previous study (Eliava et al., 2016). After one
week of recovery, animals were handled 10 min per day for 1 week. In the 3rd week after injection, animals were subjected to fear
conditioning in Context A in analogy to Figure 2A. Following the successful fear conditioning in Context A, animals were transferred
to Context B, where another round of fear conditioning was performed (see Figure 4A). Thirty minutes prior to the experiment of day 3
(exposure day), the three experimental animals received an i.p. injection of clozapine-N-oxide CNO (3mg/kg bw i.p., Tocris Biosci-
ence, Bristol, UK, dissolved in 1xPBS) to inhibit the activity of parvOT neurons. The control animals received the same volume of
vehicle (0.9%NaCl). Ninety minutes after the start of the session, the animals were euthanized with isoflurane and perfused to collect
the brains. Brain sections containing SON were used for immunohistochemical staining for OT and c-fos. Quantitative analysis of OT
versus c-fos expressing cells was performed and the results are demonstrated (in Table S4). Naive animals and animals that were
only subjected to Context A served as controls.
Stereotaxic injection of viral vectors and implantation of optic fibers
Injection of viral vectors into the rat brain was performed in analogy to Knobloch et al., 2012. If not indicated otherwise, all hypotha-
lamic nuclei were injected bilaterally using the following coordinates: SON (M-L ± 1.6mm, A-P 1.4mm, D-V 9.0mm), PVN (M-L ±
0.3mm, A-P 1.8mm, D-V 8.0mm) and AN (M-L ± 1.2mm, A-P 2.0mm, D-V 8.5mm). Point of origin for the coordinates was
Bregma and the Z level difference of Bregma and Bambda did not exceed 0.1mm (Cetin et al., 2006). Injection volume per injection
site was 300 nL (either single virus or cocktail), while all viruses used were in the range of 1012 1013 genomic copies per ml. For the
implantation of optic fibers into the CeA, we used the following coordinates:M-L ± 3.9, A-P2.5, D-V8.0while the optic fibers had a
length of 8.5 mm.
Ex Vivo Electrophysiology
Amygdala
Horizontal slices preparation. Animals were anaesthetized with an intraperitoneally administered mixture ketamine/xylazine (Imal-
gene 90 mg/kg, Rompun, 10 mg/kg). Transcardial perfusion was then performed using one of the following artificial cerebro-spinal
fluids (ACSFs) dissection solutions. For rats between 10 and 11 weeks old, an ice-cold NMDG based ACSF was used containing
(in mM): NMDG (93), KCl (2.5), NaH2PO4 (1.25), NaHCO3 (30), MgSO4 (10), CaCl2 (0.5), HEPES (20), D-Glucose (25), L-ascorbic
acid (5), Thiourea (2), Sodium pyruvate (3), N-acetyl-L-cysteine (10), Kynurenic acid (2). The pH was adjusted to 7.4 using HCl
37%, after bubbling in 95% O2 and 5% CO2 gas; bubbling was maintained throughout the duration of use of the various ACSFs.
Following decapitation, the brain was swiftly transferred into the same ice-cold ACSFs dissection solution as for transcardial perfu-
sion, and 350 mm thick horizontal slices containing the CeAwere obtained using a Leica VT1000s vibratome. After slicing, brain slices
were hemidissected and placed in a room-temperature holding chamber with normal ACSF, for a minimum of 1 h before the conduc-
tion of any experiments. Slices of 10-11 weeks old rats were placed in 35C NMDG ACSF for 10 min before transferring them to the
holding chamber at room temperature. Normal ACSF, also used during experiments, was composed of (in mM): NaCl (124), KCl (2.5),
NaH2PO4 (1.25), NaHCO3 (26), MgSO4 (2), CaCl2 (2), D-Glucose (15), adjusted for pH values of 7.4 with HCl 37% and continuously
bubbled in 95% O2 and 5% CO2 gas. All ACSFs were checked for osmolarity and kept for values between 305-312 mOsm/L. For
electrophysiology experiments, slices were transferred from the holding chamber to an immersion recording chamber and super-
fused at a rate of 2 mL/min with normal ACSF unless indicated otherwise.
CeM Neurons recordings. Pipettes were filled with an intracellular solution containing (in mM): KCl (150), HEPES (10), MgCl2 (4),
CaCl2 (0.1), BAPTA (0.1), ATP Na salt (2), GTP Na salt (0.3). pH was adjusted to 7.3 with KOH and osmolality checked to be between
290-295 mOsm/L, adjusted with sucrose if needed. All cells were hold at a membrane potential of70 mV. Series capacitances and
resistances were compensated electronically throughout the experiments using the main amplifier. Average IPSC frequencies were
calculated in 20 s windows, chosen for light stimulation at maximal effect, as determined by the maximal slope of the cumulative plot
of the number of currents using SigmaPlot 11.0. Baselines and recovery IPSC frequencies weremeasured at the beginning and end of
each recording. Z-score values were calculated by subtracting the average baseline IPSC frequency established over 70 s at the
recording beginning from individual raw values and by dividing the difference by the baseline standard deviation. Optical BL illumi-
nation of CeL OT axons expressing hChR2 was performed using light source X-Cite 110LED from Excelitas Technologies through aNeuron 103, 1–14.e1–e8, July 3, 2019 e5
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(NBQX or dOVT) of the BL illumination on the CeM IPSC frequencies, a ratio was first calculated between basal and BLmodified IPSC
frequencies minus one and that for each recording neuron, in order to obtain the BL effect. Second, the percentage of the remaining
BL illumination after pharmacological blockade was obtained by dividing the BL effect after and before drug perfusion. This is re-
ported as DBL/BL0 (%) in Figure 3B2.
SONOT neurons recordings. For this experiment, rats received viral injections of 300 nL vGATEwith rAAV-POT-FLEX-GFP as virus 3
or rAAV-POT-mCherry bilaterally into the SON. Thus, OT engram cells were labeled in green, while OT non-engram cells in red.
Recording pipettes were filled with an intracellular solution containing (in mM): KMeSO4 (125), CaCl2 (2), EGTA (1), HEPES (10),
ATPNa2 (2), GTPNa (0.3). pH was adjusted to 7.3 with KOH and osmolality checked to be between 290-295 mOsm/L, adjusted
with sucrose if needed. After whole-cell patch-clamp of identified OT neuron, the following parameters were recorded: access resis-
tance, membrane capacitance, resting potential, spontaneous EPSC amplitude and frequency, response to current injection (0 to
150 pA for 500ms, with steps of 25 pA).
Optical stimulations. Optical BL illumination of CeL OT-ergic axons expressing hChR2 was performed using light source X-Cite
110LED from Excelitas Technologies through a GFP filter, controlled with a Clampex-driven TTL pulse for 20 s at 30Hz with 10ms
pulses.
Analysis of effect of blue light. Average IPSC frequencies were calculated in 20 s windows, chosen for light stimulation at maximal
effect, as determined by the maximal slope of the cumulative plot of the number of currents using SigmaPlot 11.0. Baselines and
recovery IPSC frequencies were measured at the beginning and end of each recording. Z-score values were calculated by subtract-
ing the average baseline IPSC frequency established over 70 s at the recording beginning from individual raw values and by dividing
the difference by the baseline standard deviation.
Pharmacological assays. To quantify the pharmacological blockade (NBQX or dOVT) of the BL illumination on the CeM IPSC fre-
quencies, a ratiowas first calculated between basal andBLmodified IPSC frequenciesminus one and that for each recording neuron,
in order to obtain the BL effect. Second, the percentage of the remaining BL illumination after pharmacological blockade was
obtained by dividing the BL effect after and before drug perfusion. This is reported as DBL/BL0 (%) in Figure 3B2.
Histology
Animals were perfused through the heart with 1x PBS, followed by 4% paraformaldehyde to fixate the tissue and extracted brains
were post-fixed overnight.
The hypothalamus
Brain sections (50 mm) were collected by vibratome slicing and immunohistochemistry was performed with the following antibodies:
chicken anti-GFP (Abcam; 1:10000), anti-OT (PS38, 1:1000; mouse; kindly provided by Harold Gainer); anti-c-fos (1:1000; rabbit;
Santa Cruz Biotechnology), anti-Fluorogold (1:1000, guinea pig, Protos Biotech) and anti-DsRed (1:1000; rabbit; Clontech). GFP
signal was enhanced by FITC-conjugated IgGs, hChR2-mCherry signals by CY3-conjugated antibodies and, for different experi-
ments, other markers were visualized by FITC-conjugated; CY3-conjugated or CY5-conjugated antibodies (1:500; Jackson
Immuno-Research Laboratories). Nuclei of cells were visualized with DAPI (1:1000; Roche). All images were acquired on a confocal
Leica TCS SP5 and Zeiss LSM5microscopes; digitized images were analyzed using Adobe Photoshop. To quantify vGATE-assisted
labeling of cells, we counted all OT-, hChR2-immunoreactive neurons in the SON and PVN (8-150 neurons/section dependent on the
anterior-posterior Bregma level) in 5 animals (3 sections for SON and PVN) with the stereotactic rostro-caudal Bregma coordinates
(PVN: 1.5, 1.8, and 2.0 mm; SON: 1.1, 1.4, and 1.7 mm). Statistical significance was determined by Student’s test for
colocalization experiments, OT axon morphology and statistical analysis was performed with Prism 5 (Mac OS X). Results are
presented as mean ± SEM.
The amygdala
Staining for the vesicular glutamate transporter vGluT2. Selected sections containing the CeA were then immunolabeled for dark-
field and brightfield microscopy. For darkfield fluorescent staining, the cocktail containing different combinations of primary anti-
bodies: anti-vGluT2 (1:2000; rabbit; SySy), anti-OT (1:2000, mouse), anti-DsRed (1:1000; rabbit; Clontech), anti-GFP (1:10,000,
chicken, Abcam) were used. The named antigens were detected using appropriate secondary antibodies conjugated with fluoro-
pores of various excitation ranges (Alexa488, Alexa459, Alexa680, Thermofisher). All tissue samples, labeled with fluorescent
markers were imaged using Leica SP5 CLSM, and digitized using Adobe Photoshop software. To evaluate the CeL vGluT2 expres-
sion level, we processed the tissue for triple GFP, OT and vGluT2 immunolabeling in rats of OTConstitutive and OTvGATE groups. In total,
2000 varicosities per animal group were counted and visually examined to detect the presence of double GFP-vGluT2 signals. The
final numbers were computed as a proportion (percentage). For brightfield immunostainings, secondary antibodies conjugated to
biotin were used. Final visualization of labeling was carried out with standard ABC HRP Kit (Vector) using DAB as a chromogene.
The bright microscopic images were captured using a Nikon Eclipse microscope E200 (Software: Nikon NIS-Elements Version
4.30). We analyzed the number of varicosities and the mean length of OT fiber segments residing in the CeL to trace possible struc-
tural changes. Altogether, 72 coronal planes of 6 rats in theOTvGATE group (and 7 in control) were used for this type of analysis. Length
of GFP-positive fibers and number of axonal varicosities were measured and counted using free hand tracing and touch-count
options in the latest version of ImageJ software (NIH). All statistics were processed in group-specific comparisons between two
groups (t-Test, p < 0,05, one-tailed), always in one and the same plane of CeL (Bregma: 2,4 to 2,8).e6 Neuron 103, 1–14.e1–e8, July 3, 2019
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sula Labs., 1: 10 000), and SOM (Chemicon, 1:500), combination of DAB technique (c-Fos detection) and fluorescent labeling (for
CRH and SOM) was applied. First, the sections were incubated with c-Fos antibody and developed using biotinylated secondary
antibody, ABC kit (Vector) and conventional DAB detection protocol. Second, the c-Fos DAB-developed tissue was processed
for anti-gene retrieval procedure via ‘‘boiling’’ sections in Tris Buffer Saline pH10 at 95C for 1h for optimal detection of CRH and
SOM in the somas of CeA neurons. Afterward all primary and secondary labeling steps for CRF and SOM detection were performed
as described. The actual figures represent digital overlays of confocal bright-field scans of DAB-detected c-Fos and florescent-
labeled CRH and SOM. All images were obtained using Leica SP5 CLSM (Imaging Facility, DKFZ, Heidelberg).
Fluorogold treatment and visualization. To discriminate between magno- and parvocellular OT neurons, animals received a single
injection of Fluorogold (Santa Cruz Biotechnology, Dallas, 15mg/kg bw i.p.) 7 days prior to the perfusion. Brain sections were stained
with a primary antibody for Fluorogold (Guinea pig anti-FG, dilution 1:1000, Protos Biotech Corp, New York) and Fluorogold immu-
nosignal was visualized by secondary antibodies conjugated with CY3 (Donkey anti-rabbit, dilution 1:500, Jackson Immuno
Research, Newmarket Suffolk, UK) or Alexa 680 (Alexa 680: Goat anti-guinea-pig, 1:1000, ThermoFisher Scientific, Waltham, Mas-
sachusetts). The colocalization of Fluorogold, OT (or c-fos) and GFP signals was quantified in the PVN (SON contains only magnOT
neurons), (n = 10; 4 sections/brain). Quantitative analyses of parvo- and magnocelluar OT cells expressing GFP are presented in
Table S6.
Retrobeads infusion. For the retrograde labeling of vGATE projections terminating in the CeA we used retrobeads from LumaFluor.
We used the following coordinates for infusion in accordance with Bregma: (CeA left/right): ML: ± 4.0 mm, AP: 2.5 mm and
DV: 8 mm, without angle and an injection volume of 140 nl.
Cannula implantation. Animals were bilaterally implanted with guide cannulas for direct intra-central lateral amygdala infusions. We
used the C313G/Spc guide metallic cannulae (Plastics one, VA, USA) cut 5.8 mm below the pedestal. For this purpose, animals were
deeply anesthetized with 5% isoflurane and their heads were fixed in a stereotaxic fame. The skull was exposed and two holes were
drilled according to coordinates that were adapted from a rat brain atlas (2.3 mm rostro-caudal; 4 mm lateral; 7.5 mm dorso-ventral
relative to bregma) by comparing the typical bregma-lambda distance (9mm) with the onemeasured in the experimental animal. Two
screws were fixed to the caudal part of the skull in order to have an anchor point for the dental cement. Acrylic dental cement was
finally used to fix the cannula and the skin was sutured. CNO infusion (1 mm) occurred at 20 nl/s with a final infusion volume of 100nl
per CeA.
Measurement of Plasma ot Concentrations
Plasma preparation for LC-MS/MS analysis
50 pmol of D5-oxytocin internal standardwas added to 200 ml of lithium heparin plasma. Plasmawas acidifiedwith an equal volumeof
5% H3PO4 (v/v) and was centrifuged (14,000 x g, 5min). The resulting supernatants were collected and adjusted to 1% H3PO4 with
H2O prior to solid phase extraction (SPE). The SPE procedure was performed with a positive pressure manifold (Thermo Electron).
OASIS HLB SPE-cartridges (1cc, 30mg, Waters, Guyancourt France) were first activated with 1ml of acetonitrile (ACN) and then
washed with 1ml of H2O 99% / H3PO4 1% (v/v). The sample was loaded and the SPE-cartridge and the cartridge was washed
with 1ml of H2O 99% / H3PO4 1%. After a 1ml wash with H2O/formic acid 0.1% (v/v) and with 1 mL of ACN 5% / H2O 94.1% / formic
acid 0.1% (v/v/v), elution was performed with 500 ml of acetonitrile 60% / H2O 40% (v/v). Eluates were collected and dried under
vacuum prior to MS analysis (see below).
LC-MS/MS instrumentation and analytical conditions
LC-analyses were used to determine the presence of oxytocin in the selected reaction monitoring mode (SRM). Analyses were per-
formed on a Dionex Ultimate 3000 HPLC system (Thermo Scientific, San Jose, CA, USA) coupled with a triple quadrupole Endura
(Thermo Scientific). The system was controlled by Xcalibur v. 2.0 software (Thermo Scientific). Extracted plasma samples were
solubilized in 100 ml of H2O/formic acid 0.1% (v/v) and 20 ml of the solution were loaded into an Accucore RP-MS column (ref
17626-102130; 100 3 2.1 mm 2.6 mm, Thermo Electron) heated at 35C. Oxytocin and D5-oxytocin elutions were performed by
applying a linear gradient of buffers A/B. Buffer A corresponded to H2O 98.9% / formic acid 0.1% (v/v), whereas buffer B was
ACN 99.9%/ formic acid 0.1% (v/v). A linear gradient of 20%–95% of solvent B at 400 mL/min over 2.5min was applied followed
by a washing step (0.5min at 95% of solvent B) and an equilibration step (1min of 20% of buffer B). Qualitative analysis and quan-
tification were performed in SRM using an Endura triple quadrupole mass spectrometer and deuterated internal standards. For
ionization (positive mode), 3500V of liquid junction voltage and 350C capillary temperature was applied. The selectivity for both
Q1 and Q3 was set to 0.7Da (FWHM). The collision gas pressure of Q2 was set at 2mTorr of argon. For oxytocin and D5-oxytocin,
the selection of themonitored transitions and the optimization of the collision energywere preliminarily andmanually determined. The
transitions and the corresponding collision energies (CE) used for SRMwere the following:m/z 504.2/m/z 285.1 (CE = 15.9 eV), m/z
504.2/ m/z 487.2 (CE = 11.9 eV) and m/z 504.2/m/z 495.7 (CE = 10.2 eV) for oxytocin with 2 charges; m/z 506.8/m/z 290.2
(CE = 16.2 eV), m/z 506.8/m/z 492.9 (CE = 12.9 eV) and m/z 506.8/m/z 498.3 (CE = 10.7 eV) for D5-oxytocin (with 2 charges).
Identification of the compounds was based on precursor ion, selective fragment ions and retention times obtained for oxytocin and
D5-oxytocin internal standard. Quantification of oxytocin was done using the ratio of daughter ion response areas of the D5-oxytocin.Neuron 103, 1–14.e1–e8, July 3, 2019 e7
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To compare the signal intensity of neurons or axonal terminals we used the Image Intensity Processing function of ImageJ. Following
the detailed description of the analysis (https://imagej.net/Image_Intensity_Processing), we converted the .lif files from the confocal
microscope into TIFF images and opened them with ImageJ. For the signal intensity analysis, we used the raw data with no contrast
modifications or gamma corrections. The freehand tool was used to delineate the axonal segments and the average signal intensity of
the region of interest (ROI) was calculated via the ‘Analyze-Measure’ function. For the analysis of signal intensity in axons, the entire
length per section was used for the quantifications. The numeric values presented in the manuscript represent the output values of
ImageJ obtained from the signal intensity measurements. To specifically identify OT-positive varicosities, we first calculated the
average signal intensity (via ‘Measure-Analyze’) and standard deviation of all images included in the data analysis. Next, we used
the freehand tool / line to delineate the ROI of the axonal segments and measured the signal intensity. We defined an axon to be
‘OT-positive’, if the signal intensity within the ROI exceeded the average signal intensity of the included images by at least 4-times
the standard deviation. Axonal terminals that could not fulfill this criterion, were considered OT-negative.
QUANTIFICATION AND STATISTICAL ANALYSIS
Quantitative analysis (cell counting, c-fos expression and axon length) was performed in a double-blind manner using Fiji or Adobe
Photoshop and a superimposed grid feature. Statistical analysis was performed usingGraphPad Prism 7. p < 0.05was considered as
statistically significant (Tables S1–S6).e8 Neuron 103, 1–14.e1–e8, July 3, 2019
